Medgenics, Inc. Appoints Biopharmaceutical Industry Veteran Bill Gantz to its Board of Directors
10/17/2013 6:44:15 AM
Medgenics, Inc. (NYSE MKT:MDGN and AIM:MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces the appointment of Wilbur H. (Bill) Gantz to the Company’s Board of Directors effective October 16, 2013. With this appointment, the size of the Medgenics board increases to 10 directors.
Help employers find you! Check out all the jobs and post your resume.